Dual inhibitors of PI3K and mTOR with in vivo antitumor activity reported by Piramed and Genentech April 24, 2009
Chugai and Roche describe development, preclinical and clinical investigation of CH-4987655 April 23, 2009
Adenovirus-based prostate-specific antigen vaccine enters phase II trials for prostate cancer April 23, 2009
RSS